Philadelphia Chromosome
Information
- Disease name
- Philadelphia Chromosome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00287105 | Completed | Phase 2 | Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children | December 2005 | March 3, 2017 |
| NCT00763763 | Completed | Phase 2 | Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive | December 2004 | January 2010 |
| NCT01511289 | Completed | Phase 3 | Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients | August 2011 | |
| NCT01602952 | Completed | Phase 1/Phase 2 | Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI | July 2008 | July 13, 2018 |
| NCT03509896 | Completed | Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) | November 30, 2017 | September 28, 2019 | |
| NCT05433532 | Completed | Phase 2 | Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients | May 1, 2022 | April 13, 2024 |
| NCT06220487 | Recruiting | Phase 2 | A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL | February 1, 2024 | January 1, 2028 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010677